TrialThe oncologist2026

ECOG-ACRIN E6293: Phase II Study of Raltitrexed in Advanced Colorectal Cancer.

Chengwei Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.